CEO Letters
Overview
Mission
Leadership
Management Team
Board of Directors
Corporate Compliance
Corporate Governance
Products
Endari
Pipeline
Research Publications
Diverticulosis
Cell Sheet Engineering
News
Press Releases
Media Contacts
Media Kit
Investors
Career
Contact Us
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Pre-merger Emmaus Life Science SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Pre-merger Emmaus Life Science SEC Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
10SB12G
10SB12G/A
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFN14A
DFAN14A
DFRN14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
PREC14A
PREN14A
PRER14A
PRER14C
PRRN14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SB-2
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
Date
Form
Description
PDF
XBRL
Pages
06/02/23
4
Statement of changes in beneficial ownership of securities
1
05/15/23
8-K
Current report filing
Documents
EX-99.1
4
05/15/23
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-4.4
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-31.1
EX-31.2
EX-32.1
147
03/31/23
8-K
Current report filing
Documents
EX-99.1
4
03/31/23
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
EX-10
EX-10
EX-19
EX-23
EX-31
EX-31
EX-32
190
03/07/23
8-K
Current report filing
Documents
EX-4.1
EX-4.2
EX-4.3
13
02/21/23
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
3
01/31/23
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
01/20/23
4
Statement of changes in beneficial ownership of securities
1
01/20/23
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
Previous
1
2
3
4
5
6
7
8
9
10
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed